Jay D. Rosenbaum’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-578
| Closed | -$320K | – | 24 |
|
|
2024
Q2 | $320K | Sell |
578
-35
| -6% | -$20.1K | 1.81% | 15 |
|
|
2024
Q1 | $356K | Sell |
613
-1,080
| -64% | -$606K | 2.02% | 13 |
|
|
2023
Q4 | $899K | Sell |
1,693
-1,336
| -44% | -$647K | 2.32% | 8 |
|
|
2023
Q3 | $1.53M | Buy |
3,029
+16
| +0.5% | +$8.53K | 2.57% | 6 |
|
|
2023
Q2 | $1.57M | Buy |
3,013
+27
| +0.9% | +$14.6K | 2.52% | 7 |
|
|
2023
Q1 | $1.72M | Buy |
2,986
+32
| +1% | +$18K | 3.17% | 5 |
|
|
2022
Q4 | $1.63M | Buy |
2,954
+127
| +4% | +$67.3K | 3.51% | 3 |
|
|
2022
Q3 | $1.43M | Sell |
2,827
-1,076
| -28% | -$602K | 3.3% | 5 |
|
|
2022
Q2 | $2.12M | Sell |
3,903
-80
| -2% | -$44K | 4.1% | 3 |
|
|
2022
Q1 | $2.35M | Sell |
3,983
-95
| -2% | -$54.6K | 3.72% | 4 |
|
|
2021
Q4 | $2.72M | Buy |
4,078
+788
| +24% | +$492K | 4% | 4 |
|
|
2021
Q3 | $1.88M | Sell |
3,290
-142
| -4% | -$77.9K | 3.13% | 9 |
|
|
2021
Q2 | $1.73M | Sell |
3,432
-109
| -3% | -$51.4K | 2.87% | 9 |
|
|
2021
Q1 | $1.62M | Sell |
3,541
-278
| -7% | -$133K | 2.77% | 9 |
|
|
2020
Q4 | $1.78M | Sell |
3,819
-400
| -9% | -$188K | 3.09% | 7 |
|
|
2020
Q3 | $1.86M | Sell |
4,219
-261
| -6% | -$108K | 3.43% | 7 |
|
|
2020
Q2 | $1.62M | Sell |
4,480
-90
| -2% | -$30.2K | 3.18% | 7 |
|
|
2020
Q1 | $1.3M | Sell |
4,570
-73
| -2% | -$23K | 2.99% | 9 |
|
|
2019
Q4 | $1.51M | Buy |
4,643
+22
| +0.5% | +$6.67K | 2.67% | 12 |
|
|
2019
Q3 | $1.34M | Buy |
4,621
+69
| +2% | +$19.8K | 2.56% | 11 |
|
|
2019
Q2 | $1.34M | Sell |
4,552
-22
| -0.5% | -$6.06K | 2.53% | 12 |
|
|
2019
Q1 | $1.25M | Sell |
4,574
-40
| -0.9% | -$9.96K | 2.37% | 16 |
|
|
2018
Q4 | $1.03M | Sell |
4,614
-35
| -0.8% | -$8.21K | 2.19% | 18 |
|
|
2018
Q3 | $1.13M | Sell |
4,649
-75
| -2% | -$17.3K | 2.06% | 23 |
|
|
2018
Q2 | $978K | Sell |
4,724
-100
| -2% | -$21.2K | 1.93% | 26 |
|
|
2018
Q1 | $996K | Sell |
4,824
-276
| -5% | -$57.9K | 2.01% | 24 |
|
|
2017
Q4 | $968K | Hold |
5,100
| – | – | 1.78% | 27 |
|
|
2017
Q3 | $965K | Hold |
5,100
| – | – | 1.85% | 26 |
|
|
2017
Q2 | $890K | Buy |
5,100
+200
| +4% | +$33.6K | 1.76% | 25 |
|
|
2017
Q1 | $753K | Buy |
4,900
+160
| +3% | +$24.5K | 1.6% | 29 |
|
|
2016
Q4 | $669K | Buy |
4,740
+170
| +4% | +$25.1K | 1.55% | 30 |
|
|
2016
Q3 | $727K | Hold |
4,570
| – | – | 0.09% | 29 |
|
|
2016
Q2 | $675K | Buy |
4,570
+675
| +17% | +$99.6K | 0.1% | 28 |
|
|
2016
Q1 | $551K | Buy |
3,895
+945
| +32% | +$127K | 0.12% | 28 |
|
|
2015
Q4 | $418K | Buy |
+2,950
| New | +$393K | 0.12% | 32 |
|
|
2015
Q2 | – | Sell |
-2,625
| Closed | -$353K | – | 41 |
|
|
2015
Q1 | $353K | Buy |
+2,625
| New | +$338K | 0.08% | 37 |
|
Other funds holding TMO
Jay D. Rosenbaum's TMO Position: Q3 2024 in Review
Jay D. Rosenbaum sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 578 shares — an estimated $320K sold.
Jay D. Rosenbaum first reported a position in TMO in Q1 2015 and held it in 36 quarters. The position peaked at $2.72M in Q4 2021. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.
- Jay D. Rosenbaum reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
- Jay D. Rosenbaum sold 578 Thermo Fisher Scientific shares in Q3 2024, an estimated $320K.
- Jay D. Rosenbaum first reported a position in Thermo Fisher Scientific in Q1 2015 and held it in 36 quarters.
- Jay D. Rosenbaum's Thermo Fisher Scientific position peaked at $2.72M in Q4 2021.
- 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.
Based on Jay D. Rosenbaum's 13F filing for Q3 2024, filed 7 Nov 2024.